Centre approved anti-viral medicines to treat COVID-19 patients, says SC

The Supreme Court on Wednesday said there was an approval by the Central government on use of Remdesivir and Fabiparivir as medicines to treat COVID-19. The top court was hearing a plea seeking registration of an FIR by the CBI against ten Indian pharmaceutical firms for manufacturing and selling these two medicines for treating COVID-19 patients allegedly without valid licences.

from IndiaTV India: Google News Feed https://ift.tt/33wIR7X
via